China Traditional Chinese Medicine Holdings Co. Limited
China Traditional Chinese Medicine Holdings Co. Limited (CHIZF) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
chizf · pe ratio · data through Dec 31, 2025
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for China Traditional Chinese Medicine Holdings Co. Limited (CHIZF) measures how much investors pay for each dollar of the company's trailing earnings. CHIZF's current PE ratio of N/A is calculated by dividing its stock price of $0.27 by its TTM earnings per share of -$0.07.
Source: FMP · /ratios-ttm · /analyst-estimates · 2025-12-31
PE Ratio History
2006 – 2025 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
Historical PE Range
Past 18 fiscal years · Front-end computedMinQ1 · 25%20.2x
MedianQ3 · 75%228.4x
Max
At N/A, CHIZF's current P/E is lower than in 0% of its annual fiscal year readings over the past 18 years — historically low.
Percentile calculated from annual fiscal year data points, not by trading day. Years where PE ≤ 0 or > 9,999 are excluded.
PE Ratio vs Peers
Drug Manufacturers - Specialty & Generic · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
China Traditional Chinese Medicine Holdings Co. LimitedYou CHIZF | $1.4B | N/A | — | -$0.07 |
 CStone Pharmaceuticals CSPHF | $1.1B | N/A | — | -$0.31 |
 Evotec SE EVOTF | $1.2B | N/A | — | -$0.58 |
 Genetic Technologies Limited GNTLF | $1.3B | N/A | — | -$0.09 |
 Kissei Pharmaceutical Co., Ltd. KSPHF | $1.3B | 12.26x | -14.9% | $333.61 |
 SSY Group Limited LJUIF | $1.2B | 19.53x | +35.5% | $0.16 |
 Nippon Shinyaku Co., Ltd. NPNKF | $2.2B | 11.44x | -20.6% | $444.03 |
Industry Average 3 peers with valid PE | — | 14.41x | baseline | — |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2025-12-31Latest FY2025 | — | $-0.07 | — | |
2024-12-31 FY2024 | 228.42x | $0.01 | +1810.2% | |
2023-12-31 FY2023 | 11.96x | $0.26 | -46.2% | |
2022-12-31 FY2022 | 22.23x | $0.15 | +198.6% | |
2021-12-31 FY2021 | 7.45x | $0.38 | -19.8% | |
2020-12-31 FY2020 | 9.29x | $0.33 | -10.5% | |
2019-12-31 FY2019 | 10.38x | $0.32 | -4.2% | |
2018-12-31 FY2018 | 10.83x | $0.30 | -6.5% | |
2017-12-31 FY2017 | 11.58x | $0.26 | -22.9% | |
2016-12-31 FY2016 | 15.02x | $0.22 | -17.0% |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for China Traditional Chinese Medicine Holdings Co. Limited (CHIZF) measures how much investors pay for each dollar of the company's trailing earnings. CHIZF's current PE ratio of N/A is calculated by dividing its stock price of $0.27 by its TTM earnings per share of -$0.07.
Frequently asked questions
CHIZF pe ratio · 6 questionsCHIZF's current PE ratio is N/A as of 2026-06-08, based on a stock price of $0.27 and TTM EPS of -$0.07. Data sourced from Financial Modeling Prep via CHIZF's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · China Traditional Chinese Medicine Holdings Co. Limited SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-08